Andrew C Miller

PubHawk tracks social media discussions for 2 articles by authors named Andrew C Miller.

Claim this profile View on PubMed

Mentions

196

Peak: 33 in Feb 2021

across 2 tracked articles

Extended reach

481,727

potential audience

Total likes

1,892

Video views

62,336

Mentions per month

Feb 2021 – Aug 2025

Where it's discussed

X / Twitter106 posts
News63 articles
Blogs10 articles
Facebook6 posts
YouTube4 videos
Reddit4 posts
Bluesky3 posts

Tracked by PubHawk

Most discussed articles

Lancet Jan 2024

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.

Inder Kaul, Sharon Sawchak, Christoph U Correll, et al.

121 mentions

News 54
X 49
Blogs 8
Bluesky 3
+3 more

View analytics →

N Engl J Med Feb 2021

Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia.

Stephen K Brannan, Sharon Sawchak, Andrew C Miller, et al.

75 mentions

X 57
News 9
Facebook 4
YouTube 2
+2 more

View analytics →

From PubMed

All publications

Searching PubMed…